3 High Growth Stocks With Significant Insider Ownership On Euronext Paris

The French stock market has recently seen a boost, driven by optimism surrounding potential interest rate cuts by the European Central Bank and increased business activity due to the upcoming Paris Olympics. Against this backdrop of economic momentum, identifying growth companies with significant insider ownership can be particularly appealing for investors looking for strong alignment between management and shareholder interests.

Top 10 Growth Companies With High Insider Ownership In France

Name	Insider Ownership	Earnings Growth
Groupe OKwind Société anonyme (ENXTPA:ALOKW)	24.8%	36%
VusionGroup (ENXTPA:VU)	13.4%	25.7%
Adocia (ENXTPA:ADOC)	11.9%	63%
Icape Holding (ENXTPA:ALICA)	30.2%	35.1%
Arcure (ENXTPA:ALCUR)	21.4%	27.5%
La Française de l'Energie (ENXTPA:FDE)	19.9%	31.9%
S.M.A.I.O (ENXTPA:ALSMA)	17.4%	35.2%
Munic (ENXTPA:ALMUN)	29.2%	149.2%
MedinCell (ENXTPA:MEDCL)	15.8%	93.9%
OSE Immunotherapeutics (ENXTPA:OSE)	25.6%	5.9%

Click here to see the full list of 23 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

Lectra (ENXTPA:LSS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA provides industrial intelligence solutions for the fashion, automotive, and furniture markets across Northern Europe, Southern Europe, the Americas, and the Asia Pacific with a market cap of €1.04 billion.

Operations: Revenue segments for the company are: Americas (€172.65M), Asia-Pacific (€118.54M), and Segment Adjustment (€209.13M).

Insider Ownership: 19.6%

Lectra SA, a French growth company with high insider ownership, reported half-year sales of €262.29 million, up from €239.55 million last year. However, net income dropped to €12.51 million from €14.47 million. Despite this dip in earnings per share (€0.33 vs €0.38), analysts expect the stock price to rise by 25.8%. Lectra is trading at 47% below its estimated fair value and has no substantial insider trading activity over the past three months.

• Navigate through the intricacies of Lectra with our comprehensive analyst estimates report here.
• Our valuation report here indicates Lectra may be undervalued.

MedinCell (ENXTPA:MEDCL)

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a pharmaceutical company in France that develops long-acting injectables across various therapeutic areas, with a market cap of €526.49 million.

Operations: MedinCell generates revenue primarily from its pharmaceuticals segment, amounting to €11.95 million.

Insider Ownership: 15.8%

MedinCell S.A. reported a net loss of €25.04 million for the full year ended March 31, 2024, an improvement from last year's €32.01 million loss. Despite a slight decline in sales and revenue, the company is forecast to achieve profitability over the next three years with revenue expected to grow at 46.2% annually, outpacing market averages. Trading at 86.8% below its estimated fair value, analysts predict a stock price increase of 21.7%.

• Take a closer look at MedinCell's potential here in our earnings growth report.
• Our valuation report unveils the possibility MedinCell's shares may be trading at a discount.

Eurazeo (ENXTPA:RF)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Eurazeo SE is a private equity and venture capital firm focusing on growth capital, acquisitions, leveraged buyouts, and investments in mid-market and listed public companies with a market cap of €5.20 billion.

Operations: Revenue Segments (in millions of €):{Segment Adjustment: 354} The company's revenue segments include growth capital, acquisitions, leveraged buyouts, and investments in mid-market and listed public companies.

Insider Ownership: 12.1%

Eurazeo SE, a growth company with high insider ownership, is forecast to achieve 49.87% annual earnings growth and 47.4% revenue growth, both significantly above market averages. Despite reporting a net loss of €104.56 million for H1 2024, the company has been actively repurchasing shares worth €109 million. Trading at 84.3% below its estimated fair value, analysts expect a stock price increase of 28.3%. However, its dividend sustainability remains questionable due to insufficient earnings coverage.

• Dive into the specifics of Eurazeo here with our thorough growth forecast report.
• Our expertly prepared valuation report Eurazeo implies its share price may be lower than expected.

Seize The Opportunity

• Investigate our full lineup of 23 Fast Growing Euronext Paris Companies With High Insider Ownership right here.
• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com